乳腺癌的治疗方法内分泌治疗(Treatment of breast cancer, endocrine therapy).doc

乳腺癌的治疗方法内分泌治疗(Treatment of breast cancer, endocrine therapy).doc

  1. 1、本文档共13页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
乳腺癌的治疗方法内分泌治疗(Treatment of breast cancer, endocrine therapy)

乳腺癌的治疗方法内分泌治疗(Treatment of breast cancer, endocrine therapy) Treatment of breast cancer, endocrine therapy The treatment of breast cancer, endocrine therapy has been for more than a hundred years. Endocrine therapy for breast cancer is the most mature and effective in endocrine therapy of breast cancer. The rise of estrogen levels in the body is a major factor in the proliferation of breast cancer cells. Estrogen is secreted mainly by the ovaries of women before menopause and is secreted by the adrenal glands and parts of the adipose tissue after menopause. Estrogen and progesterone receptors are present in breast cells, which cause mammary glands to proliferate with hormone levels. Research shows that about 2/3 of breast cancer cells contain a certain amount of estrogen receptor (estrogen receptor, ER), this type of breast cancer called ER estrogen receptor positive breast cancer; 40-50% breast cancer containing progesterone receptor (progesterone receptor, PR), this type of breast cancer called PR pregnant hormone receptor positive breast cancer. ER estrogen receptor or PR progesterone receptor positive breast cancer is sensitive to hormone therapy. At present, the endocrine therapy to object to the ER or PR progesterone receptor positive tumors, slow growth, long disease-free survival after surgery, with or without bone and soft tissue metastasis, asymptomatic visceral metastases and previous effective endocrine therapy in breast cancer patients. For patients with receptor positive breast cancer, most patients are now expected to have chemotherapy and endocrine therapy. However, in the past two treatment time controversial, in recent years a large clinical trial results showed that endocrine therapy after chemotherapy and radiotherapy should be started, one can improve the survival of patients with breast cancer, on the other hand can increase the effect of chemotherapy. Endocrine therapy for different duration is different, the commonly used tamoxifen (tamoxifen

您可能关注的文档

文档评论(0)

f8r9t5c + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:8000054077000003

1亿VIP精品文档

相关文档